Lynn Durham

Company: STALICLA

Job title: Chief executive officer & Founder

Seminars:

Clinical Translation of Precision Medicine in a First Clinically & Biologically Defined Subgroup of Patients with Autism Spectrum Disorder 9:30 am

A first clinically and biologically defined subgroup of ASD patients, named ASD-Phen1, was clinically validated in 2 prospectives biosampling studies with an observed incidence of 20-25% of the enrolled ASD population This subgroup was then biologically validated through multi-omics characterization revealing specific molecular signatures for ASD-Phen1 patients that were found to be reversed by STALICLA's…Read more

day: Conference Day 1 AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.